1. Home
  2. WNS vs SRRK Comparison

WNS vs SRRK Comparison

Compare WNS & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNS
  • SRRK
  • Stock Information
  • Founded
  • WNS 1996
  • SRRK 2012
  • Country
  • WNS India
  • SRRK United States
  • Employees
  • WNS N/A
  • SRRK N/A
  • Industry
  • WNS Business Services
  • SRRK Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WNS Consumer Discretionary
  • SRRK Health Care
  • Exchange
  • WNS Nasdaq
  • SRRK Nasdaq
  • Market Cap
  • WNS 3.2B
  • SRRK 3.0B
  • IPO Year
  • WNS N/A
  • SRRK 2018
  • Fundamental
  • Price
  • WNS $76.33
  • SRRK $38.96
  • Analyst Decision
  • WNS Hold
  • SRRK Strong Buy
  • Analyst Count
  • WNS 8
  • SRRK 9
  • Target Price
  • WNS $66.60
  • SRRK $45.25
  • AVG Volume (30 Days)
  • WNS 1.1M
  • SRRK 2.7M
  • Earning Date
  • WNS 10-16-2025
  • SRRK 11-11-2025
  • Dividend Yield
  • WNS N/A
  • SRRK N/A
  • EPS Growth
  • WNS 21.19
  • SRRK N/A
  • EPS
  • WNS 3.60
  • SRRK N/A
  • Revenue
  • WNS $1,345,621,000.00
  • SRRK N/A
  • Revenue This Year
  • WNS $7.23
  • SRRK N/A
  • Revenue Next Year
  • WNS $9.29
  • SRRK $1,996.18
  • P/E Ratio
  • WNS $21.22
  • SRRK N/A
  • Revenue Growth
  • WNS 1.94
  • SRRK N/A
  • 52 Week Low
  • WNS $42.62
  • SRRK $22.71
  • 52 Week High
  • WNS $76.37
  • SRRK $46.98
  • Technical
  • Relative Strength Index (RSI)
  • WNS 77.08
  • SRRK 65.02
  • Support Level
  • WNS $76.22
  • SRRK $34.52
  • Resistance Level
  • WNS $76.35
  • SRRK $41.01
  • Average True Range (ATR)
  • WNS 0.11
  • SRRK 2.51
  • MACD
  • WNS -0.09
  • SRRK 0.64
  • Stochastic Oscillator
  • WNS 93.25
  • SRRK 94.92

About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)

WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: